FKBP1A and acute myeloid leukemia: Several previously published studies suggested small molecule inhibitors that interact with the Peptidyl-prolyl cis-trans isomerase FKBP1A (FKB1A) protein and suppress cell proliferation in acute myeloid leukemia phenotypes via inhibition of MTORC1 activity [56,57].